Proteasome Accessory Factor C (pafC) Is a novel gene Involved in Mycobacterium Intrinsic Resistance to broad-spectrum antibiotics - Fluoroquinolones

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Li, Qiming ^a   Xie, Longxiang ^a   Long, Quanxin ^a,b   Mao, Jinxiao ^a   Li, Hui ^a   Zhou, Mingliang ^a   Xie, Jianping ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HYDROGEN PEROXIDE; MOXIFLOXACIN; QUINOLONE DERIVATIVE; SCAVENGER; THIOUREA; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; FREE RADICAL SCAVENGERS; GENE KNOCKOUT TECHNIQUES; HYDROGEN PEROXIDE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MUTAGENESIS, INSERTIONAL; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; THIOUREA;

EID: 84936797404     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11910     Document Type: Article

References (56)

1. Organization WH. Global tuberculosis report 2013. World Health Organization (2013).
2. Ginsberg, A. M. & Spigelman, M. Challenges in tuberculosis drug research and development. Nature 13, 290-294 (2007).
3. Wright, A. et al. Epidemiology of antituberculosis drug resistance 2002-07: An updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. The Lancet 373, 1861-1873 (2009).
4. Zignol, M. et al. Surveillance of anti-tuberculosis drug resistance in the world: An updated analysis, 2007-2010. Bulletin of the world Health Organization 90, 111-119 (2012).
5. Jarlier, V. & Nikaido, H. Mycobacterial cell wall: Structure and role in natural resistance to antibiotics. FEMS Microbiol Lett 123, 11-18 (1994).
6. Silver, L. L. Challenges of antibacterial discovery. Clinical microbiology reviews 24, 71-109 (2011).
7. da Silva, P. E. A., Von Groll, A., Martin, A. & Palomino, J. C. Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis. FEMS Immunology & Medical Microbiology 63, 1-9 (2011).
8. Ren, H. & Liu J. AsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugs. Antimicrobial agents and chemotherapy 50, 250-255 (2006).
9. Velayutham, B. V. et al. Sputum Culture Conversion With Moxifloxacin-Containing Regimens in the Treatment of Patients With Newly Diagnosed Sputum-Positive Pulmonary Tuberculosis in South India. Clinical Infectious Diseases, ciu550 (2014).
10. Shim, T. S. & Jo, K.-W. Medical treatment of pulmonary multidrug-resistant tuberculosis. Infection & chemotherapy 45, 367-374 (2013).
11. Seung, K. et al. Salvage therapy for multidrug-resistant tuberculosis. Clinical Microbiology and Infection 20, 441-446 (2014).
12. Ginsburg, A. S., Grosset, J. H. & Bishai, W. R. Fluoroquinolones, tuberculosis, and resistance. The Lancet infectious diseases 3, 432-442 (2003).
13. Drlica, K. & Zhao, X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiology and molecular biology reviews 61, 377-392 (1997).
14. Maruri, F. et al. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. Journal of Antimicrobial Chemotherapy 67, 819-831 (2012).
15. Pearce, M. J., Mintseris, J., Ferreyra, J., Gygi, S. P. & Darwin, K. H. Ubiquitin-like protein involved in the proteasome pathway of Mycobacterium tuberculosis. Science 322, 1104-1107 (2008).
16. Elharar, Y. et al. Survival of mycobacteria depends on proteasome?mediated amino acid recycling under nutrient limitation. The EMBO journal 33, 1802-1814 (2014).
17. Lin, G. et al. Inhibitors selective for mycobacterial versus human proteasomes. Nature 461, 621-626 (2009).
18. Festa, R. A., Pearce, M. J. & Darwin, K. H. Characterization of the proteasome accessory factor (paf) operon in Mycobacterium tuberculosis. Journal of bacteriology 189, 3044-3050 (2007).
19. Rawat, M., Kovacevic, S., Billman-Jacobe, H. & Av-Gay, Y. Inactivation of mshB, a key gene in the mycothiol biosynthesis pathway in Mycobacterium smegmatis. Microbiology 149, 1341-1349 (2003).
20. Darwin, K. H., Ehrt, S., Gutierrez-Ramos, J.-C., Weich, N. & Nathan, C. F. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science 302, 1963-1966 (2003).
21. Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A. & Collins, J. J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810 (2007).
22. Winterbourn, C. C. Toxicity of iron and hydrogen peroxide: The Fenton reaction. Toxicology letters 82, 969-974 (1995).
23. Ryan, B. M. et al. Efflux in bacteria: What do we really know about it? Expert opinion on investigational drugs 10, 1409-1422 (2001).
24. Jiang, X. et al. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microbial drug resistance 14, 7-11 (2008).
25. Silva, P. E. et al. Characterization of P55, a Multidrug Efflux Pump inMycobacterium bovis and Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 45, 800-804 (2001).
26. De Rossi, E. et al. The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis. Molecular medicine 8, 714 (2002).
27. Gupta, A. K. et al. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microbial drug resistance 16, 21-28 (2010).
28. Wilson, M. et al. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proceedings of the National Academy of Sciences 96, 12833-12838 (1999).
29. Choudhuri, B. et al. Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. Biochem J 367, 279-285 (2002).
30. Pasca, M. R. et al. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 48, 3175-3178 (2004).
31. Danilchanka, O., Mailaender, C. & Niederweis, M. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 52, 2503-2511 (2008).
32. Pasca, M. R., Guglierame, P., De Rossi, E., Zara, F. & Riccardi, G. mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis. Antimicrobial agents and chemotherapy 49, 4775-4777 (2005).
33. Wolff, K. A. et al. Protein kinase G is required for intrinsic antibiotic resistance in mycobacteria. Antimicrobial agents and chemotherapy 53, 3515-3519 (2009).
34. Bowman, J. & Ghosh, P. A complex regulatory network controlling intrinsic multidrug resistance in Mycobacterium smegmatis. Molecular microbiology 91, 121-134 (2014).
35. Nandakumar, M., Nathan, C. & Rhee, K. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nature communications 5, 4306-4306 (2013).
36. Liu, J., Takiff, H. E. & Nikaido, H. Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump. Journal of bacteriology 178, 3791-3795 (1996).
37. Takiff, H. et al. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proceedings of the National Academy of Sciences 93, 362-366 (1996).
38. Montero, C., Mateu, G., Rodriguez, R. & Takiff, H. Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA. Antimicrobial agents and chemotherapy 45, 3387-3392 (2001).
39. Wang, X., Zhao, X., Malik, M. & Drlica, K. Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death. Journal of Antimicrobial Chemotherapy 65, 520-524 (2010).
40. Liu, Y. & Imlay, J. A. Cell death from antibiotics without the involvement of reactive oxygen species. Science 339, 1210-1213 (2013).
41. Keren, I., Wu, Y., Inocencio, J., Mulcahy, L. R. & Lewis, K. Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339, 1213-1216 (2013).
42. Dwyer, D. J., Collins, J. J. & Walker, G. C. Unraveling the physiological complexities of antibiotic lethality. Annual review of pharmacology and toxicology 55, 313-332 (2015).
43. Davies, B. W. et al. Hydroxyurea induces hydroxyl radical-mediated cell death in Escherichia coli. Molecular cell 36, 845-860 (2009).
44. Wang, X. & Zhao, X. Contribution of oxidative damage to antimicrobial lethality. Antimicrobial agents and chemotherapy 53, 1395-1402 (2009).
45. Yeom, J., Imlay, J. A. & Park, W. Iron homeostasis affects antibiotic-mediated cell death in Pseudomonas species. Journal of Biological Chemistry 285, 22689-22695 (2010).
46. Dong, T. G. et al. Generation of reactive oxygen species by lethal attacks from competing microbes. Proceedings of the National Academy of Sciences 112, 2181-2186 (2015).
47. Piccaro, G., Pietraforte, D., Giannoni, F., Mustazzolu, A. & Fattorini, L. Rifampin Induces Hydroxyl Radical Formation in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 58, 7527-7533 (2014).
48. Kumar, A. et al. Redox homeostasis in mycobacteria: The key to tuberculosis control? Expert reviews in molecular medicine 13, e39 (2011).
49. Makarova, K., Anantharaman, V., Grishin, N., Koonin, E. & Aravind, L. CARF and WYL domains: Ligand-binding regulators of prokaryotic defense systems. Frontiers in genetics 5, 102 (2014).
50. Gottesman, S. Proteolysis in Bacterial Regulatory Circuits1 1. Annual review of cell and developmental biology 19, 565-587 (2003).
51. Collins, G. A. & Tansey, W. P. The proteasome: A utility tool for transcription? Current opinion in genetics & development 16, 197-202 (2006).
52. Festa, R. A. et al. A novel copper-responsive regulon in Mycobacterium tuberculosis. Molecular microbiology 79, 133-148 (2011).
53. Long, Q. et al. Involvement of Holliday junction resolvase in fluoroquinolone-mediated killing of Mycobacterium smegmatis. Antimicrobial agents and chemotherapy, AAC. 04434-04414 (2014).
54. Murry, J., Sassetti, C., Lane, J., Xie, Z. & Rubin, E. Transposon site hybridization in Mycobacterium tuberculosis. Methods in molecular biology (Clifton, NJ) 416, 45 (2008).
55. Siegrist, M. & Rubin, E. Phage transposon mutagenesis. Methods in molecular biology (Clifton, NJ) 465, 311-323 (2008).
56. Bauer, A., Kirby, W., Sherris, J. C. & turck, Turck, M. Antibiotic susceptibility testing by a standardized single disk method. American journal of clinical pathology 45, 493 (1966).